1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global Microbiome Therapeutics
Market
5.
Voice of Customer
6.
Clinical Trial Analysis
7. Global Microbiome
Therapeutics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Type (FMT v/s Microbiome Drugs)
7.2.2.
By Application (C. Difficile, Crohn’s Disease,
Inflammatory Bowel Disease, Diabetes, Others)
7.2.3. By
Region
7.2.4.
By Company (2021)
7.3.
Product Market Map
8. North America Microbiome
Therapeutics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Type
8.2.2.
By Application
8.2.3.
By Country
8.3.
North America: Country Analysis
8.3.1.
United States Microbiome Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Application
8.3.2.
Mexico Microbiome Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Application
8.3.3.
Canada Microbiome Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Application
9. Europe Microbiome
Therapeutics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Type
9.2.2.
By Application
9.2.3.
By Country
9.3.
Europe: Country Analysis
9.3.1.
France Microbiome Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Application
9.3.2.
Germany Microbiome Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Application
9.3.3.
United Kingdom Microbiome Therapeutics
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Application
9.3.4.
Italy Microbiome Therapeutics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Application
9.3.5.
Spain Microbiome Therapeutics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Type
9.3.5.2.2.
By Application
10. Asia-Pacific Microbiome
Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Type
10.2.2.
By Application
10.2.3.
By Country
10.3.
Asia-Pacific: Country Analysis
10.3.1.
China Microbiome Therapeutics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Application
10.3.2.
India Microbiome Therapeutics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Application
10.3.3.
South Korea Microbiome Therapeutics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Application
10.3.4.
Japan Microbiome Therapeutics Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Application
10.3.5.
Australia Microbiome Therapeutics Market Outlook
10.3.5.1.
Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2.
Market Share & Forecast
10.3.5.2.1.
By Type
10.3.5.2.2.
By Application
11. South America Microbiome
Therapeutics Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Type
11.2.2.
By Application
11.2.3.
By Country
11.3.
South America: Country Analysis
11.3.1.
Brazil Microbiome Therapeutics Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Type
11.3.1.2.2.
By Application
11.3.2.
Argentina Microbiome Therapeutics Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Type
11.3.2.2.2.
By Application
11.3.3.
Colombia Microbiome Therapeutics Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Type
11.3.3.2.2.
By Application
12. Middle East and
Africa Microbiome Therapeutics Market Outlook
12.1.
Market Size & Forecast
12.1.1.
By Value
12.2.
Market Share & Forecast
12.2.1.
By Type
12.2.2.
By Application
12.2.3.
By Country
12.3.
MEA: Country Analysis
12.3.1.
South Africa Microbiome Therapeutics Market Outlook
12.3.1.1.
Market Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2.
Market Share & Forecast
12.3.1.2.1.
By Type
12.3.1.2.2.
By Application
12.3.2.
Saudi Arabia Microbiome Therapeutics Market Outlook
12.3.2.1.
Market Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2.
Market Share & Forecast
12.3.2.2.1.
By Type
12.3.2.2.2.
By Application
12.3.3.
UAE Microbiome Therapeutics Market Outlook
12.3.3.1.
Market Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2.
Market Share & Forecast
12.3.3.2.1.
By Type
12.3.3.2.2.
By Application
13.
Market Dynamics
13.1.
Drivers
13.2.
Challenges
14.
Market Trends & Developments
15.
Competitive Landscape
15.1.
4D Pharma plc
15.2.
Enterome SA
15.3.
Finch Therapeutics Group, Inc.
15.4.
Vedanta Bioscience, Inc.
15.5.
Seres Therapeutics, Inc.
15.6.
Microbiotica Limited
15.7.
Destiny Pharma plc
15.8.
Taisho Pharmaceutical Holdings Co., Ltd.
15.9.
AOBiome Therapeutics, Inc.
15.10.
Ferring Pharmaceuticals SA
16. Strategic Recommendations